missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human KCTD15 Synthetic Peptide
Synthetic Peptide
Brand: Invitrogen™ PEP0817
This item is not returnable.
View return policy
Description
KCTD15 Synthetic Peptide, PEP-0817, from Invitrogen.
Childhood and adult obesity in the United States and to a lesser extent the rest of the world has increased dramatically over the past decade. Both environmental and genetic factors are involved in the onset and progression of weight gain. Recently, the potassium channel KCTD15 was identified as a genetic loci associated with higher than normal body mass index (BMI) in humans along with genes such as GNPDA2, MTCH2, FTO, and TMEM18. Further studies on single nucleotide polymorphisms (SNPs) in non-diabetic and diabetic patients showed that FTO was most strongly associated with obesity while MTCH2 and GNPDA2 were still significantly associated with higher than normal BMI levels. At least two isoforms of KCTD15 are known to exist.
Specifications
| 79047 | |
| purified | |
| Human KCTD15 | |
| -20°C | |
| Liquid | |
| Blocking Assay, Control | |
| No | |
| Peptide | |
| RUO - research use only |
| Human | |
| Q96SI1 | |
| 200 μg/mL | |
| Synthetic Peptide | |
| PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 | |
| KCTD15 | |
| 0.02% sodium azide | |
| 50 μg | |
| PBS |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Invitrogen™ Human KCTD15 Synthetic Peptide > 50 μg; Unlabeled
Spot an opportunity for improvement?Share a Content Correction
